158 related articles for article (PubMed ID: 7506452)
21. Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus.
Ericzon BG; Eusufzai S; Söderdahl G; Duraj F; Einarsson K; Angelin B
Transplantation; 1997 Jan; 63(1):74-80. PubMed ID: 9000664
[TBL] [Abstract][Full Text] [Related]
22. Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?
Franz M; Regele H; Schmaldienst S; Stummvoll HK; Hörl WH; Pohanka E
Transplantation; 1998 Nov; 66(9):1258-62. PubMed ID: 9825827
[TBL] [Abstract][Full Text] [Related]
23. Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection.
Matsumoto Y; McCaughan GW; Painter DM; Bishop GA
Transplantation; 1993 Jul; 56(1):69-75. PubMed ID: 8333070
[TBL] [Abstract][Full Text] [Related]
24. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A
Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635
[TBL] [Abstract][Full Text] [Related]
25. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.
Taler SJ; Textor SC; Canzanello VJ; Schwartz L; Porayko M; Wiesner RH; Krom RA
Transplantation; 1996 Dec; 62(11):1588-92. PubMed ID: 8970613
[TBL] [Abstract][Full Text] [Related]
26. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients.
Textor SC; Wiesner R; Wilson DJ; Porayko M; Romero JC; Burnett JC; Gores G; Hay E; Dickson ER; Krom RA
Transplantation; 1993 Jun; 55(6):1332-9. PubMed ID: 7685934
[TBL] [Abstract][Full Text] [Related]
27. Significance of central perivenulitis in pediatric liver transplantation.
Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
[TBL] [Abstract][Full Text] [Related]
28. Low level of interleukin 10 synthesis during liver allograft rejection.
Conti F; Boulland ML; Leroy-Viard K; Chereau C; Dousset B; Soubrane O; Weill B; Calmus Y
Lab Invest; 1998 Oct; 78(10):1281-9. PubMed ID: 9800954
[TBL] [Abstract][Full Text] [Related]
29. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
Stegall MD; Wachs ME; Everson G; Steinberg T; Bilir B; Shrestha R; Karrer F; Kam I
Transplantation; 1997 Dec; 64(12):1755-60. PubMed ID: 9422416
[TBL] [Abstract][Full Text] [Related]
30. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
31. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
[TBL] [Abstract][Full Text] [Related]
32. Central venulitis in the allograft liver: a clinicopathologic study.
Tsamandas AC; Jain AB; Felekouras ES; Fung JJ; Demetris AJ; Lee RG
Transplantation; 1997 Jul; 64(2):252-7. PubMed ID: 9256183
[TBL] [Abstract][Full Text] [Related]
33. Long-term comparison of rat model of chronic allograft rejection of orthotopic small bowel transplantation induced by cyclosporine versus tacrolimus.
Li Y; Zhu Y; Wang J; Wei W; Wu B; Li J
Transplant Proc; 2013 Jun; 45(5):1811-5. PubMed ID: 23769050
[TBL] [Abstract][Full Text] [Related]
34. Histological patterns of rejection using oral microemulsified cyclosporine and tacrolimus (FK506) as monotherapy induction after orthotopic liver transplantation.
Chau TN; Quaglia A; Rolles K; Burroughs AK; Dhillon AP
Liver; 2001 Oct; 21(5):329-34. PubMed ID: 11589769
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation.
Gruessner RW; Fryer JP; Fasola C; Nakhleh RE; Gruessner AC; Kim S; Dunn DL; Pirenne J; Bekersky I; Benedetti E
Transplantation; 1995 Jan; 59(2):164-71. PubMed ID: 7530871
[TBL] [Abstract][Full Text] [Related]
37. Day-5 protocol liver allograft biopsies document early rejection episodes and are predictive of recurrent rejection.
Brunt EM; Peters MG; Flye MW; Hanto DW
Surgery; 1992 May; 111(5):511-7. PubMed ID: 1317977
[TBL] [Abstract][Full Text] [Related]
38. The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?
Mueller AR; Platz KP; Blumhardt G; Bechstein WO; Steinmüller T; Christe W; Hopf U; Lobeck H; Neuhaus P
Clin Transplant; 1995 Jun; 9(3 Pt 1):176-84. PubMed ID: 7549057
[TBL] [Abstract][Full Text] [Related]
39. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
[TBL] [Abstract][Full Text] [Related]
40. Proximal renal tubular acidosis secondary to FK506 in pediatric liver transplant patients.
O'Gorman MA; Fivush B; Wise B; Colombani P; Burdick J; Schwarz KB
Clin Transplant; 1995 Aug; 9(4):312-6. PubMed ID: 7579739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
